The book's title, The Pissing Evil, taken from Thomas Willis's 17th century discourse on diabetes, may consign it to the top shelf of the book case rather than the coffee table in homes inhabited by young children. If you can get past that, you will find the book lives up to its billing as 'the most complete history of diabetes ever written'. Tattersall takes us on a journey Some might think he has occasionally missed the chance to relate historical themes to the present day, most notably von Mering's description of phloridzin glycosuria to the use of sodium-glucose co-transporter 2 inhibitors to treat type 2 diabetes. The acknowledgment that self blood glucose monitoring, for which Tattersall shared the credit, cannot be the end of the diabetes monitoring story is not linked to the introduction of flash and continuous glucose monitoring.
Robert Gregory
I particularly enjoyed the account of the University Group Diabetes Program (UGDP) trial of treatments for non-insulin dependent diabetes, a well-intentioned but poorly-conducted study, the fall-out from which gave birth to the UK Prospective Diabetes Study, the brainchild of Robert Turner who, according to Tattersall, wrote his body weight in grant applications to fund it. This reviewer had not appreciated that the results of the UGDP trial had been leaked to the press before publication, causing the share price of certain pharmaceutical companies to collapse. Today's investors are no less interested in the cardiovascular outcome trials of new to market diabetes drugs.
There are gems to be discovered throughout the book. I was thrilled to read Kussmaul's own description of his eponymous respiration that characterises diabetic ketoacidosis (DKA). The discovery of insulin is a chapter in itself; the simplified (and wrong) version has been painstakingly dissected and the record set as straight as it is ever likely to be. Readers will have to decide for themselves whether the Nobel Prize committee got it right.
The management of DKA in 16-18-year-olds is a controversial topic in the UK at the moment, so this reviewer looked for enlightenment in the chapter on 'Diabetic Coma and Ketoacidosis'. Tattersall mentions two papers from the 1960s describing five patients aged 9-16 years who developed cerebral oedema, and the subsequent description by Clements et al in 1971 of changes in cerebrospinal fluid pressure during treatment of DKA.
Oddly, the book stops abruptly with a final chapter on 'Miscellaneous Complications'. This reviewer was expecting a brief reflective conclusion, but perhaps to end as it does with a description of one of Tattersall's own cases is sufficient and appropriate.
This book will be a rewarding read for healthcare professionals and researchers in diabetes, and provides a rich supply of anecdotes for consultant ward rounds. VOLUME 18 ISSUE 1 l JANUARY/FEBRUARY/MARCH 2018
